Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The IgE-mediated hypersensitivity pathway is an immune response characterized by the production of IgE antibodies against specific allergens. This pathway is central to allergic diseases and anaphylaxis. It involves sensitization (IgE production and binding to mast cells/basophils) and subsequent re-exposure, which triggers mast cell/basophil degranulation and release of inflammatory mediators, leading to allergic symptoms.
Multiple, depending on the drug. Examples include: Histamine receptor blockade, reduction of inflammation, IgE neutralization, inhibition of leukotriene synthesis/action, stabilization of mast cell membranes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IgE-Mediated Hypersensitivity Pathway.